Table 1. Patient characteristics (n=50).
| Characteristics | % | n |
|---|---|---|
| Age (years) | ||
| Median | 64 | |
| Range | 46–79 | |
| Histological type | ||
| Serous | 78 | 39 |
| Endometrioid | 4 | 2 |
| Others | 18 | 9 |
| Histological grade | ||
| 1 | 16 | 8 |
| 2 | 28 | 14 |
| 3 | 26 | 13 |
| Unknown | 30 | 15 |
| Number of earlier chemotherapy regimens | ||
| One | 84 | 42 |
| Two | 16 | 8 |
| Response to earlier platinum–taxane regimen | ||
| Clinical complete | 42 | 21 |
| Clinical partial | 26 | 13 |
| Stabilisation | 16 | 8 |
| Progression | 10 | 5 |
| Unknown | 6 | 3 |
| Performance status | ||
| 0 | 32 | 16 |
| 1 | 68 | 34 |
| Ascites | 48 | 24 |
| Measurable lesion | ||
| <5 cm | 40 | 20 |
| ⩾5 cm | 10 | 5 |
| No (CA 125 ⩾40 UI ml–1) | 46 | 23 |
| Not evaluable | 4 | 2 |
| Number of disease sites a | ||
| 1 | 55 | 27 |
| >1 | 45 | 23 |
a
Peritoneal or retroperitoneal or single visceral disease.